Designed specifically for bioreactor-scale workflows, the system reportedly requires less than 15 minutes of hands-on time.

A structurally tuned HPV cancer SNA vaccine boosts CD8⁺ T‑cell responses and slows tumor growth in mice and patient‑derived spheroids, a study shows.

Products released at this year's meeting covered a broad range of applications from sustainable labware to protein assays to instruments.

It turns out we might be building up our brain when we exercise.” Betley is corresponding author of the researchers’ published paper in Neuron, titled “ Exercise-induced activation of ventromedial ...

Studies reveal the therapeutic mechanism of action for levetiracetam to prevent the production of Aβ and, consequently, downstream irreversible damage.

Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.

This eBook explores how innovation and shifting patient expectations are reshaping modern diagnostics—and advancing progress toward global STI elimination goals.

The company, based in Norcross, GA, manufactures more than 900 DNA and RNA isolation products used in clinical research, biotechnology, genomics, and agriculture.

From SLAS in Boston, Julianna LeMieux and Uduak Thomas share highlights, key sessions, and takeaways on automation.

A new study has found bacterial sugars that cause neurodegenerative immune response, providing a mechanism for therapeutic intervention.

Unchained Labs launched Stuntman during the SLAS meeting in Boston: an automation platform that combines native, natural-language AI with flexible hardware.

Michelle Lee, PhD, unpacks how physical AI that integrate scientific reasoning with the wet lab will accelerate biological discovery.